A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma

Figure 3

Construction and validation of a prognostic model based on NCGs. (a) Distribution of survival status (upper) and risk scores (lower) for the training datasets. (b) Distribution of survival status (upper) and risk scores (lower) for the validation datasets. (c, d) The Kaplan-Meier curves of overall survival for the high- and low-risk groups in the training and validation datasets. (e, f) Time-dependent receiver operating characteristic curves for the risk score in the training and validation datasets.

(a)

(b)

(c)

(d)

(e)

(f)